Already have an account? Login
New York, NY
$5M - $10M
Edmund Truell (Director),
David Deming (Director),
Harvey Brandwein (President),
Ferid Murad (Director),
Curtis Robb (Executive Officer),
Monil Shah (Executive Officer),
Charles Cherington (Director),
George Iii (Director),
Lawrence Wolf (Director),
Mark Leuchtenberger (Executive Officer, Director),
John Halpern (Director),
Zygmund Roth (Executive Officer)
About IRX Therapeutics
CategoriesTechnology Companies in New York
Is This Your Company?
|Chief Scientific OfficerNew York, NY||New York, NY||Dec 1, 2012||$325,000|
|Chief Scientific OfficerNew York, NY||New York, NY||Dec 1, 2009||$187,491|
|Quality Control ScientistNew York, NY||New York, NY||Sep 19, 2018||$64,626|
|Quality Control ScientistNew York, NY||New York, NY||Feb 16, 2018||$64,626|
|Quality Control ScientistNew York, NY||New York, NY||Apr 12, 2018||$64,626|
|Business Development AnalystNew York, NY||New York, NY||Sep 13, 2010||$60,590|
To get more results, try adjusting your search by changing your filters.
$5M - $10M
IRX Therapeutics Financing Rounds
Have you worked at IRX Therapeutics? Help other job seekers by rating IRX Therapeutics.
Aw snap, no jobs found.
You can find out what it is like to work at IRX Therapeutics, also known as IRX THERAPEUTICS INC, IRX Therapeutics, IRX Therapeutics, Inc. and Irx Therapeutics.
Zippia gives an in-depth look into the details of IRX Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about IRX Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at IRX Therapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of IRX Therapeutics and its employees or that of Zippia.